165 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
14 Dec 22
Departure of Directors or Certain Officers
4:07pm
of the Board of Directors of Ligand Pharmaceuticals Incorporated (the “Company”) approved a base salary increase and target cash bonus opportunity … case, effective as of December 5, 2022, in connection with each executive’s recent promotion to such position.
The base salary and target cash bonus
8-K
cl2h fhtn
5 Dec 22
Departure of Directors or Certain Officers
7:03am
8-K
2fj jbyli8
4 Nov 22
Unaudited Pro Forma Condensed Consolidated Financial Statements
4:08pm
425
6muw9kls71t0yz9nc4
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.1
nzz8oytw6
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-10.1
pc3 m0sm48lkz
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
ll37d9 fvfvgfj1
27 Jan 22
Departure of Directors or Certain Officers
4:02pm
8-K
38j7jvzzs8dgozu6g0
28 Jan 21
Entry into a Material Definitive Agreement
4:42pm
8-K/A
EX-99.2
fkagp9 x3qwes1lg5kh
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-2.1
73yihbdrfcfn3 ydk5
13 Oct 20
Entry into a Material Definitive Agreement
8:44am